IRIS
GIACOMETTI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.280
EU - Europa 8.921
AS - Asia 8.395
SA - Sud America 1.948
Continente sconosciuto - Info sul continente non disponibili 482
AF - Africa 454
OC - Oceania 18
Totale 40.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.672
SG - Singapore 2.721
VN - Vietnam 1.703
RU - Federazione Russa 1.513
UA - Ucraina 1.493
BR - Brasile 1.468
CN - Cina 1.330
IT - Italia 1.324
IE - Irlanda 825
DE - Germania 815
SE - Svezia 793
TR - Turchia 730
HK - Hong Kong 721
FR - Francia 578
DK - Danimarca 531
FI - Finlandia 401
GB - Regno Unito 303
KR - Corea 293
CA - Canada 232
CI - Costa d'Avorio 199
AR - Argentina 173
BD - Bangladesh 173
IN - India 172
MX - Messico 130
EC - Ecuador 84
NL - Olanda 77
JP - Giappone 73
ZA - Sudafrica 72
IQ - Iraq 68
ID - Indonesia 64
CO - Colombia 59
PL - Polonia 51
MA - Marocco 50
VE - Venezuela 48
PK - Pakistan 46
CR - Costa Rica 44
PY - Paraguay 37
UZ - Uzbekistan 35
AT - Austria 32
HN - Honduras 32
ES - Italia 31
CL - Cile 29
IL - Israele 29
IR - Iran 29
PH - Filippine 29
TT - Trinidad e Tobago 29
SV - El Salvador 26
BE - Belgio 25
TN - Tunisia 24
MY - Malesia 23
CW - ???statistics.table.value.countryCode.CW??? 22
PE - Perù 22
EG - Egitto 20
KE - Kenya 20
GT - Guatemala 19
PR - Porto Rico 19
NI - Nicaragua 18
RO - Romania 18
SA - Arabia Saudita 18
JO - Giordania 17
NP - Nepal 16
UY - Uruguay 16
JM - Giamaica 15
LT - Lituania 15
RS - Serbia 15
AE - Emirati Arabi Uniti 14
DZ - Algeria 14
OM - Oman 14
CH - Svizzera 13
DO - Repubblica Dominicana 13
GP - Guadalupe 13
KZ - Kazakistan 13
BG - Bulgaria 12
AZ - Azerbaigian 11
EU - Europa 11
AU - Australia 10
PS - Palestinian Territory 10
SC - Seychelles 9
ET - Etiopia 8
HR - Croazia 8
PA - Panama 8
AL - Albania 7
BO - Bolivia 7
CG - Congo 6
CZ - Repubblica Ceca 6
SN - Senegal 6
TH - Thailandia 6
CY - Cipro 5
KW - Kuwait 5
LB - Libano 5
MD - Moldavia 5
TW - Taiwan 5
BB - Barbados 4
EE - Estonia 4
HU - Ungheria 4
SY - Repubblica araba siriana 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
Totale 39.981
Salva come PNG Salva come JPEG
Città #
Ashburn 3.368
Singapore 1.645
Jacksonville 1.481
Chandler 1.157
Fairfield 1.111
Dallas 1.023
San Jose 822
Dublin 815
Boardman 742
Council Bluffs 740
Hong Kong 692
Wilmington 584
Ho Chi Minh City 539
New York 486
Woodbridge 485
Hanoi 436
Seattle 408
Houston 400
Beijing 345
Des Moines 340
Cambridge 333
Princeton 328
Ann Arbor 321
Lawrence 313
San Mateo 309
Moscow 293
Lauterbourg 277
Los Angeles 271
The Dalles 270
Abidjan 199
Hefei 190
San Diego 141
São Paulo 141
Centro 124
Turin 123
Munich 120
Santa Clara 118
Milan 117
Buffalo 116
Phoenix 109
Da Nang 100
Orem 85
Chicago 74
London 70
Helsinki 69
Rome 61
Turku 59
Guangzhou 56
Montreal 56
Redmond 56
Tokyo 56
Haiphong 53
Shanghai 52
Rio de Janeiro 46
Ancona 45
Chennai 45
Miano 45
Norwalk 43
Mexico City 42
Brooklyn 41
Denver 41
Izmir 41
Atlanta 40
Johannesburg 40
Warsaw 38
Nuremberg 34
Tashkent 34
Frankfurt am Main 33
Belo Horizonte 32
Columbus 32
Washington 32
San José 31
Chelsea 30
Naples 30
Brasília 29
Guayaquil 29
Wuhan 29
Porto 28
Biên Hòa 25
Dhaka 25
Manchester 25
Ottawa 25
Pune 25
San Francisco 25
Toronto 25
Amsterdam 24
Brussels 24
Salt Lake City 24
San Salvador 24
Hải Dương 23
Stockholm 23
Baghdad 22
Curitiba 22
Mumbai 22
Willemstad 22
Boston 21
Falls Church 21
Ninh Bình 21
Buenos Aires 20
Can Tho 20
Totale 24.097
Salva come PNG Salva come JPEG
Nome #
Supplementation with tocotrienols from Bixa orellana improves the in vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of infected wound 448
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 341
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 277
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 240
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 222
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 217
Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study 211
An (Italian) proposal for a comprehensive approach to infections across the surgical pathway 210
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 209
Anticryptosporidial activity of paromomycin. 207
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 205
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 200
ACTIVITY OF THE NEW ANTIFUNGAL TRIAZOLE, POSACONAZOLE, AGAINST CRYPTOCOCCUS NEOFORMANS 198
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 193
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 193
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 193
Antimicrobial activity of polycationic peptides 192
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 192
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 189
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study 187
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 179
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 173
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 172
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 172
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 171
Epidemiology and microbiology of surgical wound infections. 167
SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region 167
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 167
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 164
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 163
[Prevalence of Toxocara spp in public playgrounds in a town of Central Italy] 161
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 159
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 159
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 159
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 158
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 158
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 158
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 157
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 157
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV. 157
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy 156
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 156
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 155
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 154
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 152
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 151
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 151
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 151
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 151
OC-34 Clinical outcome of switching to a dual drug regimen (2DR) vs. switching or remaining on a triple (3DR) regimen in the setting of a viral load ≤50 copies/mL 150
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 150
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 149
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 148
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 148
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 147
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 147
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 147
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 146
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 146
Anticryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems. 145
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 144
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 143
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy 143
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 142
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 142
Tocilizumab in COVID-19 interstitial pneumonia 142
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 141
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 141
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 140
Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence 140
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 139
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 139
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 138
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 138
Animal models commonly used to study quorum-sensing inhibitors. 138
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 137
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 137
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 136
Antiretroviral therapy management and rationalisation of available resources 136
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 135
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 135
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 135
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 135
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 134
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 133
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 132
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 132
In-vitro activity of rifabutin and albendazolo singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. 131
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 131
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 131
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 131
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 131
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 131
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 130
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 130
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 130
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 130
Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients 130
Genomic Analysis of a Linezolid-Resistant Staphylococcus capitis Causing Bacteremia: Report from a University Hospital in Central Italy 129
LL-37 protects rats against lethal gram-negative sepsis. 129
Totale 16.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 183.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.330
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.604 0 0 0 0 34 173 119 149 167 295 192 475
2022/20233.901 406 364 291 267 282 623 5 204 1.018 20 300 121
2023/20242.261 427 45 136 378 404 463 33 63 16 24 32 240
2024/20254.878 644 417 286 130 165 236 445 186 1.100 299 435 535
2025/202614.004 745 1.118 1.145 1.617 1.268 857 2.479 1.413 1.308 1.151 309 594
2026/20273.820 798 708 685 1.615 14 0 0 0 0 0 0 0
Totale 40.498